AbCellera Investor Conference Presentation Deck

CORPORATE OVERVIEW COPYRIGHT © ABCELLERA 14 PORTFOLIO DIVERSIFIED ACROSS MODALITIES, PARTNER SIZE, AND DEAL TYPE. 84 7 partner-initiated partner-initiated discovery programs co-development programs 38 partners 7 molecules in the clinic 15 pre-partnered program targets initiated (GPCR, ion channels and TCE) 2 authorized antibody therapies REGENERON gsk NOVARTIS GILEAD Ablynx A SANOFI COMPANY EMPIRICO Autolus TACHYON Lilly EVEREST MEDICINES SANOFI igences Rallybio angios Lyell teva moderna TM REMAKING MEDICINE Pfizer KODIAK DENALI X Invetx MERCK BILL & MELINDA GATES foundation

View entire presentation